Steady-state brain glucose transport kinetics re-evaluated with a four-state conformational model

A linear relationship between plasma and brain glucose concentrations has been observed and modeled using reversible enzyme kinetics. This model assumes a direct, bidirectional exchange of glucose across the blood-brain barrier. However, this approach does not account for carrier conformational changes or asymmetry in transport. Prior research has shown that glucose enters the brain via facilitative transporters, but the precise mechanisms of trans-acceleration and isomerization remain unclear. No prior work had resolved how brain glucose might influence transporter activity itself. That uncertainty drove the development of a more detailed model that includes multiple compartments and conformational states. This gap motivated researchers to explore a four-state model that incorporates trans-acceleration and inhibition effects. The need to integrate these factors into a unified framework became apparent as experimental data revealed inconsistencies with simpler models. This paper introduces a new approach that expands on existing knowledge by addressing transport asymmetry and iso-inhibition. The goal is to better understand how glucose transport adapts under varying physiological conditions.

The aim of this research is to refine the understanding of brain glucose transport by incorporating a four-state conformational model into a multi-compartment framework. The specific problem addressed is the lack of a model that accounts for trans-acceleration and asymmetry of glucose transporters. The motivation stems from the need to explain observed glucose transport behavior under different plasma glucose levels. The study seeks to determine whether a more complex model can better describe experimental data than simpler reversible models. Researchers propose that including carrier isomerization and iso-inhibition could improve predictive accuracy. The four-state model allows for both influx and efflux of glucose and introduces inhibition by brain glucose. This approach enables a more comprehensive analysis of transport dynamics. The study's purpose is to evaluate whether this expanded model aligns with existing data and provides new insights into glucose transport mechanisms.

The researchers employed a multi-compartment model that includes blood, endothelial cells, and brain compartments. They integrated a four-state conformational exchange model to describe glucose transport dynamics. Transport was modeled using four kinetic parameters: K(t), T(max), CMR(glc), and K(ii). Experimental data from prior studies using biochemical methods and NMR spectroscopy were analyzed to estimate these parameters. The model accounts for trans-acceleration and asymmetry of the glucose transporter. The iso-inhibition constant K(ii) was calculated to assess the effect of brain glucose on carrier isomerization. The model was validated by comparing predicted outcomes with published data on brain glucose concentrations. The approach combines theoretical modeling with empirical data to refine transport parameter estimates.

The four-state model successfully described brain glucose as a function of plasma glucose using a single analytical equation. The apparent half-saturation constant K(t) ranged from 1.5 to 3.5 mM across the data. The ratio T(max)/CMR(glc) was found to be between 4.6 and 5.6. The iso-inhibition constant K(ii) ranged from 51 to 149 mM. These values were consistent with prior estimates from simpler models. The model predicted that brain glucose approaches a maximum concentration under certain conditions. However, iso-inhibition was not significant when plasma glucose was below 25 mM. The reversible model remained sufficient for most experimental conditions. These findings suggest that the four-state model provides a more comprehensive framework for understanding glucose transport.

The four-state conformational model successfully incorporates trans-acceleration and iso-inhibition into glucose transport analysis. The model predicts that brain glucose concentration approaches a maximum under high plasma glucose conditions. The estimated parameters K(t), T(max)/CMR(glc), and K(ii) align with previously reported values. The authors suggest that iso-inhibition is unlikely to play a major role under normal physiological conditions. The model accounts for both influx and efflux of glucose across the blood-brain barrier. The results indicate that the reversible model remains adequate for most experimental scenarios. The four-state model provides a more detailed description of transport dynamics. The study concludes that the expanded model enhances understanding of glucose transport under varying conditions.